October Pharma S.A.E reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EGP 655.04 million compared to EGP 543.4 million a year ago. Net income was EGP 119.79 million compared to EGP 88.26 million a year ago.

Basic earnings per share from continuing operations was EGP 9.985 compared to EGP 7.355 a year ago.